NasdaqCM:ASTHHealthcare
Astrana Health Buyback Expansion And Control Weakness Create Key Turning Point
Astrana Health reported record annual financial results and beat fourth quarter earnings expectations.
The company doubled its share repurchase authorization, signaling a larger planned buyback program.
Astrana Health also delayed its 10 K filing due to a material weakness in acquisition and purchase accounting processes.
Astrana Health, NasdaqCM:ASTH, is drawing fresh attention after pairing record financial results with a larger share buyback and an acknowledged internal control issue...